Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 8, 2014Annals of Pharmacotherapy

Recent Evidence for Pharmacological Treatment of Idiopathic Pulmonary Fibrosis

View Full Paper
Ask AI
Bookmark
Share

Authors

JCJordan R. CovveyPhiladelphia College of Osteopathic MedicineEMErin ManclAbbVie (United States)

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Covvey et al. (2014) studied this question.

synapsesocial.com/papers/6a7bfc58a540d02696c2b4a8https://doi.org/10.1177/1060028014551015
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Tissue Factor Expression and Fibrin Deposition in the Lungs of Patients with Idiopathic Pulmonary Fibrosis and Systemic Sclerosis1997 · 153 citations
  2. 2Oxidant-mediated epithelial cell injury in idiopathic pulmonary fibrosis.1987 · 356 citations
  3. 3Treatment of Idiopathic Pulmonary Fibrosis With Ambrisentan2013 · 562 citations
  4. 4High-Dose Acetylcysteine in Idiopathic Pulmonary Fibrosis2005 · 984 citations
  5. 5BUILD-3: A Randomized, Controlled Trial of Bosentan in Idiopathic Pulmonary Fibrosis2011 · 721 citations